tiprankstipranks
Advertisement
Advertisement
Talphera announces 50% patient enrollment of the NEPHRO-CRRT clinical trial
PremiumThe FlyTalphera announces 50% patient enrollment of the NEPHRO-CRRT clinical trial
1M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago
Talphera, Inc. Earnings Call: Balancing Achievements and Challenges
Premium
Company Announcements
Talphera, Inc. Earnings Call: Balancing Achievements and Challenges
5M ago
Talphera’s Niyad Study: A Potential Game-Changer in Renal Therapy
PremiumCompany AnnouncementsTalphera’s Niyad Study: A Potential Game-Changer in Renal Therapy
6M ago
Talphera Holds Annual Meeting with Key Decisions
Premium
Company Announcements
Talphera Holds Annual Meeting with Key Decisions
6M ago
Talphera Regains Nasdaq Compliance After Grace Period
Premium
Company Announcements
Talphera Regains Nasdaq Compliance After Grace Period
6M ago
Talphera, Inc. Earnings Call Highlights Strategic Progress
PremiumCompany AnnouncementsTalphera, Inc. Earnings Call Highlights Strategic Progress
8M ago
Talphera enrolls 17 patients in 70-patient pivotal NEPHRO CRRT clinical trial
Premium
The Fly
Talphera enrolls 17 patients in 70-patient pivotal NEPHRO CRRT clinical trial
8M ago
Positive Outlook for Talphera: Buy Rating Backed by Promising Niyad Trial Progress and Strong Financial Position
Premium
Ratings
Positive Outlook for Talphera: Buy Rating Backed by Promising Niyad Trial Progress and Strong Financial Position
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100